A labeled metabolite of Pitavastatin. Recent studies have shown that conversion between acid and lactone forms occurs in the body, drug-drug interaction should be considered on both acid and lactone forms. The inhibitory effects of statins on CYP metabolic activities and MDR1 transporting activity were investigated using human liver microsomes and MDR1-overexpressing LLC-GA5-COL150 cells Form: Off-White to Pale Yellow Solid Melting Point: 72-75C Solubility: Chloroform, Ethyl Acetate
Molekulargewicht:
408.48
Formulierung:
Off-White to Pale Yellow Solid
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
